Insulin lispro-aabc

FDA Drug Profile — LYUMJEV Tempo Pen, LYUMJEV, LYUMJEV Junior KwikPen, LYUMJEV KwikPen

Insulin lispro-aabc is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand names including LYUMJEV Tempo Pen, LYUMJEV, LYUMJEV Junior KwikPen. Available dosage form: injection, solution.

Drug details

Generic Name
Insulin lispro-aabc
Brand Names
LYUMJEV Tempo Pen, LYUMJEV, LYUMJEV Junior KwikPen, LYUMJEV KwikPen
Application Number
BLA761109
Sponsor
Eli Lilly And Company
NDC Codes
19
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS, INTRAVENOUS
Active Ingredients
INSULIN LISPRO

Indications and Usage

1 INDICATIONS AND USAGE LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.